CDK8 inhibition sequesters Med1 at EWS-FLI enhancers [ChIP-seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 22 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Ewing sarcomaThis series is part of our curated briefing on it.
- Samples
- 22 samples: 8 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE302426_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1290400 and SRA study SRP600263. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 16 samples.
How we read this: 8 replicated groups read from 22 sample titles; they account for 16 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9103818 A673_EWSFLI-AID_NChIP-H3K27ac_DMSO_rep1 A673_EWSFLI-AID_NChIP-H…
- GSM9103819 A673_EWSFLI-AID_NChIP-H3K27ac_DMSO_rep2 A673_EWSFLI-AID_NChIP-H…
- GSM9103820 A673_EWSFLI-AID_NChIP-H3K27ac_IAA_rep1 A673_EWSFLI-AID_NChIP-H…
- GSM9103821 A673_EWSFLI-AID_NChIP-H3K27ac_IAA_rep2 A673_EWSFLI-AID_NChIP-H…
- GSM9103822 A673_EWSFLI-AID_NChIP-Input_DMSO
- GSM9103823 A673_EWSFLI-AID_NChIP-Input_IAA
- GSM9103824 A673_NChIP-H3K27ac_DMSO_rep1 A673_NChIP-H3K27ac_DMSO
- GSM9103825 A673_NChIP-H3K27ac_DMSO_rep2 A673_NChIP-H3K27ac_DMSO
- GSM9103826 A673_NChIP-H3K27ac_SW39_rep1 A673_NChIP-H3K27ac_SW39
- GSM9103827 A673_NChIP-H3K27ac_SW39_rep2 A673_NChIP-H3K27ac_SW39
- GSM9103828 A673_NChIP-Input_DMSO
- GSM9103829 A673_NChIP-Input_SW39
- GSM9103830 A673_XChIP-MED1_DMSO_rep1 A673_XChIP-MED1_DMSO
- GSM9103831 A673_XChIP-MED1_DMSO_rep2 A673_XChIP-MED1_DMSO
- GSM9103832 A673_XChIP-MED1_SW39_rep1 A673_XChIP-MED1_SW39
- GSM9103833 A673_XChIP-MED1_SW39_rep2 A673_XChIP-MED1_SW39
- GSM9103834 A673_XChIP-INPUT_DMSO
- GSM9103835 A673_XChIP-INPUT_SW39
- GSM9103836 A673_NChIP-H3K9ac_DMSO_rep1 A673_NChIP-H3K9ac_DMSO
- GSM9103837 A673_NChIP-H3K9ac_DMSO_rep2 A673_NChIP-H3K9ac_DMSO
- GSM9103838 A673_NChIP-H3K9ac_SW39_rep1 A673_NChIP-H3K9ac_SW39
- GSM9103839 A673_NChIP-H3K9ac_SW39_rep2 A673_NChIP-H3K9ac_SW39
- GSE302425 CDK8 inhibition sequesters Med1 at EWS-FLI enhancers [CUT&RUN] 12 samples same disease briefing · shares ews-fli, cdk8, med1, inhibition, sequesters, enhancers
- GSE302424 CDK8 inhibition sequesters Med1 at EWS-FLI enhancers [ATAC-seq] 6 samples same disease briefing · shares ews-fli, cdk8, med1, inhibition, sequesters, enhancers
- GSE304126 CDK8 inhibition sequesters Med1 at EWS-FLI enhancers [RNA-Seq] 68 samples same disease briefing · shares ews-fli, cdk8, med1, inhibition, sequesters, enhancers
- GSE266666 Select chromatin complexes are essential drivers of pathogenic enhancer activity and gene expression in Ewing sarcoma [ChIP-Seq] 101 samples same disease briefing · shares chip-seq
- GSE272960 EWS-FLI1 Expression in Human Embryonic Mesenchymal Stem Cells Leads to Defective DNA Damage Repair and Ewing Sarcoma 24 samples same disease briefing · shares ews-fli
- GSE314154 STAG2 loss amplifies EWS-FLI1-driven microsatellite enhancer activity promoting Ewing's sarcoma aggressiveness [RNA-Seq] 20 samples same disease briefing · shares ews-fli
- GSE263234 ARID1A IDR Targets EWS-FLI1 Condensates and Finetunes Productive Chromatin Remodeling 12 samples same disease briefing · shares ews-fli
- GSE263504 Identification of genes regulated by knockdown of EWS-FLI1 in Ewing sarcoma cells. 12 samples same disease briefing · shares ews-fli
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.